UB Paderborn / Katalog / Suche / in CDI

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q

Nature communications, 2023-12, Vol.14 (1), p.8006-15, Article 8006

2023

Volltextzugriff (PDF)

A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study

PloS one, 2018-12, Vol.13 (12), p.e0208936-e0208936

2018

Volltextzugriff (PDF)

Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group

Clinical cancer research, 2016-11, Vol.22 (22), p.5582-5591

2016

Volltextzugriff (PDF)

Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour

Journal of medical genetics, 2016-06, Vol.53 (6), p.385-388

2016

Volltextzugriff (PDF)

Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation

Neoplasia (New York, N.Y.), 2016-02, Vol.18 (2), p.71-81

2016

Volltextzugriff (PDF)

MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours

Nature communications, 2015-12, Vol.6 (1), p.10013, Article 10013

2015

Volltextzugriff (PDF)

Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target

Experimental cell research, 2013-03, Vol.319 (5), p.612-622

2013

Volltextzugriff (PDF)

Rare variant detection using family-based sequencing analysis

Proceedings of the National Academy of Sciences - PNAS, 2013-03, Vol.110 (10), p.3985-3990

2013

Volltextzugriff (PDF)

Clinically Relevant Subsets Identified by Gene Expression Patterns Support a Revised Ontogenic Model of Wilms Tumor: A Children's Oncology Group Study

Neoplasia (New York, N.Y.), 2012-08, Vol.14 (8), p.742-IN21

2012

Volltextzugriff (PDF)

WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study

Journal of clinical oncology, 2011-02, Vol.29 (6), p.698-703

2011

Volltextzugriff (PDF)

Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene

Nature reviews. Cancer, 2011-02, Vol.11 (2), p.111

Huff, Vicki

2011

Volltextzugriff (PDF)

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

The Journal of clinical investigation, 2011-01, Vol.121 (1), p.174-183

2011

Volltextzugriff (PDF)

Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562

Clinical cancer research, 2009-10, Vol.15 (19), p.5985-5992

2009

Volltextzugriff (PDF)

Wilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors

Genes chromosomes & cancer, 2008-06, Vol.47 (6), p.461-470

2008

Volltextzugriff (PDF)

Wilms Tumor Genetics: A New, UnX-pected Twist to the Story

Cancer cell, 2007-02, Vol.11 (2), p.105-107

Huff, Vicki

2007

Volltextzugriff (PDF)

The Wilms Tumor Gene, Wt1, Is Required for Sox9 Expression and Maintenance of Tubular Architecture in the Developing Testis

Proceedings of the National Academy of Sciences - PNAS, 2006-08, Vol.103 (32), p.11987-11992

2006

Volltextzugriff (PDF)

Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

Journal of clinical oncology, 2005-10, Vol.23 (29), p.7312-7321

2005

Volltextzugriff (PDF)

Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors

Genes chromosomes & cancer, 2005-06, Vol.43 (2), p.172-180

2005

Volltextzugriff (PDF)

Familial Wilms tumor

American journal of medical genetics. Part C, Seminars in medical genetics, 2004-08, Vol.129C (1), p.29-34

2004

Volltextzugriff (PDF)

Twenty-four new cases of WT1 germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development

American journal of medical genetics, 2004-06, Vol.127A (3), p.249-257

2004

Volltextzugriff (PDF)

Characterization of a Wilms tumor in a 9‐year‐old girl with trisomy 18

American journal of medical genetics, 2003-08, Vol.121A (1), p.52-55

2003

Volltextzugriff (PDF)

Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors

Oncogene, 2003-06, Vol.22 (24), p.3821-3826

2003

Volltextzugriff (PDF)

Absence of PPP2R1A mutations in Wilms tumor

Oncogene, 2001-04, Vol.20 (16), p.2050-2054

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children's Oncology Group AREN18B5-Q

A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study

A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor

Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group

Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour

Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation

MLLT1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours

Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors

Ubiquitin specific protease 18 (Usp18) is a WT1 transcriptional target

Rare variant detection using family-based sequencing analysis

Clinically Relevant Subsets Identified by Gene Expression Patterns Support a Revised Ontogenic Model of Wilms Tumor: A Children's Oncology Group Study

WT1 Mutation and 11P15 Loss of Heterozygosity Predict Relapse in Very Low-Risk Wilms Tumors Treated With Surgery Alone: A Children's Oncology Group Study

Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

Loss of Heterozygosity at 2q37 in Sporadic Wilms' Tumor: Putative Role for miR-562

Wilms tumor genetics: Mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors

Wilms Tumor Genetics: A New, UnX-pected Twist to the Story

The Wilms Tumor Gene, Wt1, Is Required for Sox9 Expression and Maintenance of Tubular Architecture in the Developing Testis

Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group

Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors

Familial Wilms tumor

Twenty-four new cases of WT1 germline mutations and review of the literature: Genotype/phenotype correlations for Wilms tumor development

Characterization of a Wilms tumor in a 9‐year‐old girl with trisomy 18

Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors

Absence of PPP2R1A mutations in Wilms tumor

Aktive Filter

Suchergebnisse filtern